1. Home
  2. STIM vs STRO Comparison

STIM vs STRO Comparison

Compare STIM & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.43

Market Cap

105.5M

Sector

Health Care

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$9.92

Market Cap

94.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STIM
STRO
Founded
2003
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.5M
94.9M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
STIM
STRO
Price
$1.43
$9.92
Analyst Decision
Strong Buy
Hold
Analyst Count
2
7
Target Price
$7.00
$19.67
AVG Volume (30 Days)
1.3M
112.9K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$129,873,000.00
$105,646,000.00
Revenue This Year
$101.67
$62.61
Revenue Next Year
$10.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
78.61
N/A
52 Week Low
$1.23
$5.23
52 Week High
$5.92
$21.50

Technical Indicators

Market Signals
Indicator
STIM
STRO
Relative Strength Index (RSI) 40.71 78.91
Support Level $1.28 $9.53
Resistance Level $1.79 $10.10
Average True Range (ATR) 0.15 0.93
MACD 0.06 0.15
Stochastic Oscillator 28.57 98.52

Price Performance

Historical Comparison
STIM
STRO

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: